MC

Matt Cohen

Managing Partner at Osage University Partners

Philadelphia, Pennsylvania

Overview 

Matt Cohen is the Managing Partner at Osage University Partners, with a background in lifesciences and biotechnology. He has held various roles within OUP, including Partner and Principal, and has expertise in financial modeling and strategic consulting. Cohen's career highlights include his leadership at Osage University Partners and his extensive experience in the lifesciences industry, spanning from consulting to managing investments in healthcare startups.

Work Experience 

  • Managing Partner

    2022 - Current

    Osage University Partners (OUP) is a venture capital fund that invests in spinouts from a network of over 100 affiliated universities and research institutions. OUP has over $600 million in assets under management and has invested in over 125 university spinouts across both tech and life sciences. A list of our portfolio can be found on our website: https://oup.vc/portfolio/ At OUP, I’m focused on venture stage therapeutics, research tools, diagnostics, and medical device companies.

  • Partner

    2019 - 2022

  • Principal

    2016 - 2018

  • Senior Associate

    2013 - 2016

OUP is a venture capital fund investing in start-ups that commercialize university research.

  • Board Member

    2020

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.

Raised $9,149,999.00 from North Carolina Biotechnology Center.

  • Consultant

    2011 - 2013

    Strategic consultant serving clients across the spectrum of pharmaceutical, biotech, diagnostic, life science, healthcare, and private equity. Engagements include strategy development, market assessment, commercialization support, portfolio development, acquisition / licensing, valuation, and diligence / transaction support. Experience across small molecule, biologics, medical devices, and diagnostics in a variety of therapeutic areas (e.g., oncology, virology, cardiology, diabetes, CNS, nephrology, orphan) across the U.S., EU, Japan, and emerging markets. Sample engagements include: ‒Commercial model and launch design (patient journey, initiatives to address market pain points) for a major bio-pharma with an industry-leading virology franchise ‒Partnering strategy for oncology personalized medicine / companion diagnostic development for a major bio-pharma ‒Asset analysis, prioritization, and long-term growth strategy for an oncology franchise at a major bio-pharma

  • Senior Life Sciences Specialist

    2012 - 2013

  • Life Sciences Specialist

    2011 - 2012

  • Co-President

    2010 - 2011

    A 100+ graduate student organization that creates awareness of management consulting through education and preparation for successful recruitment into strategy management consulting.

  • Project Manager / Life Sciences Consultant

    2010 - 2010

    · Managed the client and an interdisciplinary team of 7 people, directed team and led meetings · Co-wrote computer script which identified 329 new customer targets from ~700 scientific journal articles · Determined academic market size for new product to be $440K/year; strategized market penetration

Latest Articles 

Articles About Matt

Relevant Websites